share_log

Eli Lilly and Co | 8-K: Estimated Third Quarter Acquired In-Process Research and Development and Development Milestone Charges

Oct 13, 2022 04:08
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.